http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9618392-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c29ebbacb306f9b12e38ffad61728746
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D329-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
filingDate 1995-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e9d3d6d070a5a969ea21a1ec199d4ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20f8c4ebd429cd4038f18e566326830c
publicationDate 1996-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9618392-A1
titleOfInvention Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
abstract There are provided compositions for, and a method of, treating malignancies which comprise effective amounts of a novel combined therapy comprising a platinum compound and a tellurium or selenium compound, e.g., ammonium trichloro(dioxoethylene-O,O-tellurate), and administering the respective compounds simultaneously or separately.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1796660-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1796660-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1924254-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7629382-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7652065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8623908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1924254-A4
priorityDate 1994-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4761490-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129770107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128355931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128063721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129302252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128682662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129842321

Total number of triples: 55.